| Alexandra Paige Mareck, CNP | |
|
4656 Excelsior Blvd, St Louis Park, MN 55416-4938 | |
| (952) 929-0140 | |
| Not Available |
| Full Name | Alexandra Paige Mareck |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4656 Excelsior Blvd, St Louis Park, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053077602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 8559 (Minnesota) | Primary |
| Entity Name | Children's Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932208808 PECOS PAC ID: 2668370966 Enrollment ID: O20040406000939 |
News Archive
Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed a Letter of Intent with Green Medicals LLC to acquire equity interest in up to eight (8) medical marijuana dispensaries within the state of Colorado.
AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of inviCRO's innovative software platforms.
Helix BioMedix, Inc., a developer of bioactive peptides, announced financial results for the year ended December 31, 2009.
Too much antibiotic can decimate the normal intestinal microbiota, which may never recover its former diversity. That, in turn, renders the GI tract vulnerable to being colonized by pathogens. Now researchers from Memorial Sloan-Kettering Cancer Center, New York, NY, and Centro Superior de Investigaci-n en Salud P-blica, Valencia, Spain, show that reintroducing normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) from the intestinal tracts of mice..
Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Paige Mareck, CNP 4656 Excelsior Blvd, St Louis Park, MN 55416-4938 Ph: (952) 929-0140 | Alexandra Paige Mareck, CNP 4656 Excelsior Blvd, St Louis Park, MN 55416-4938 Ph: (952) 929-0140 |
News Archive
Cannabis Medical Solutions Inc., a leading company specializing in both brick-and-mortar and online merchant payment solutions and financial security products for medical marijuana dispensaries and high-risk merchant accounts, today announced that the Company has signed a Letter of Intent with Green Medicals LLC to acquire equity interest in up to eight (8) medical marijuana dispensaries within the state of Colorado.
AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of inviCRO's innovative software platforms.
Helix BioMedix, Inc., a developer of bioactive peptides, announced financial results for the year ended December 31, 2009.
Too much antibiotic can decimate the normal intestinal microbiota, which may never recover its former diversity. That, in turn, renders the GI tract vulnerable to being colonized by pathogens. Now researchers from Memorial Sloan-Kettering Cancer Center, New York, NY, and Centro Superior de Investigaci-n en Salud P-blica, Valencia, Spain, show that reintroducing normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) from the intestinal tracts of mice..
Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.
› Verified 4 days ago
Camille Ashley Schwarzrock, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3931 Louisiana Ave S, St Louis Park, MN 55426 Phone: 952-993-3230 Fax: 952-993-1748 | |
Rachel Anderson, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4201 Excelsior Blvd, St Louis Park, MN 55416 Phone: 952-933-8900 | |
Haley Carlock, DNP, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1155 Ford Rd, Suite B, St Louis Park, MN 55426 Phone: 952-378-1800 Fax: 952-378-1714 | |
Catherine Ann Watson Lund, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4700 Park Glen Rd, St Louis Park, MN 55416 Phone: 952-922-4200 Fax: 952-922-4301 | |
Anna Melnichuk, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, St Louis Park, MN 55426 Phone: 952-993-3246 Fax: 952-993-3010 | |
Oluwasegun Paul David, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5775 Wayzata Blvd Fl 2, St Louis Park, MN 55416 Phone: 952-525-4500 | |
Tiffany Rae Krebsbach, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6500 Excelsior Blvd, St Louis Park, MN 55426 Phone: 952-993-3246 |